Search results for: 'pharmaceutical R&D service market'

Data science, software engineering, and materials knowledge researchers must collaborate to bridge the gaps in materials R&D and accelerate digital transformation. To introduce digital innovation into the lab, scientists need to develop new skills and manage larger data volumes more efficiently using tools such as artificial intelligence (AI), big ...

Virtual simulation and modeling technologies are transforming chemicals and materials research and development (R&D) by enabling precise design, testing, and optimization of materials and processes. These technologies facilitate the modeling of complex chemical reactions, allow for accurate predictions of material properties, and make production pr...

17 Jun 2024  |  Global  |  Technology Research

Materials Industry: R&D Outlook and Technology Growth Opportunities, 2024 2028

Steady Funding and the Focus on Investments are Bolstering R&D Efforts in Material Development

Infographics

×

The materials industry stands on the brink of transformative innovation, driven by an unwavering commitment to research and development (R&D) excellence and the allure of technological advancements. In the industry's rapidly evolving landscape, characterized by global integration and evolving consumer demands, stakeholders face a multitude of chall...

05 Apr 2023  |  Asia Pacific  |  Market Outlook

Asia-Pacific Pharmaceutical Industry Outlook, 2023

Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry

Infographics

×

Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japan,...

This outlook identifies the trends shaping the global pharmaceutical landscape. The growth of the global pharmaceutical industry will plateau in 2023 due to a slowdown of the biologics segment as a result of a decrease in the uptake of COVID-19 vaccines and therapeutics. Market growth will be low in the United States and Europe and highest in the A...

Continuous manufacturing (CM) is a method for manufacturing end-to-end pharmaceutical products on a single, uninterrupted production line. While batch manufacturing requires transporting, testing, and refeeding materials from one process to the next, continuous processes execute all testing, feeding, and processing inline at a single manufacturing ...

08 Mar 2022  |  North America  |  Market Outlook

Global Pharmaceuticals Outlook, 2022

The Digitalization of the Pharmaceuticals Value Chain is Opening up New Growth Opportunities for Stakeholders

Infographics

×

Key Issues Addressed

Frost & Sullivan offers an outlook for the global pharmaceuticals market for 2022-2026, including emerging trends and growth opportunities. Prioritizing booster doses over initial dose coverage is negatively impacting the global mitigation of the COVID-19 pandemic, which is resulting in severe implications on health and social and economic well-bei...

Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generation of evidence to support the drug’s value proposi...

05 Sep 2024  |  Global  |  Technology Research

R&D Investment Analysis of the Medtech Sector

Artificial Intelligence Integration and Medical Devices Miniaturization to Drive Transformational Growth

Infographics

×

Before the COVID-19 pandemic, medical technology (medtech) registered significant investment in R&D. However, the investment trend declined post-pandemic but is gradually picking up momentum. Top medtech companies invest about 7% to 8% of their total revenues toward the R&D of novel products or to enhance existing products. The key sources for medt...